Analysis of quality of life in patients with knee osteoarthritis after treatment with autologous leukocyte-rich and leukocyte-poor platelet-rich plasma / Ye. Goliuk [et al.] // Клітинна та органна трансплантологія. - 2020. - Том 8, N 2. - P131-138 MeSH-головна: ОСТЕОАРТРИТ КОЛЕННОГО СУСТАВА -- OSTEOARTHRITIS, KNEE (терапия) МЕДИЦИНА РЕГЕНЕРАТИВНАЯ -- REGENERATIVE MEDICINE (методы) ТРОМБОЦИТ-НАСЫЩЕННАЯ ПЛАЗМА -- PLATELET-RICH PLASMA КАЧЕСТВО ЖИЗНИ -- QUALITY OF LIFE Анотація: In recent years, there is a growing interest in the application of regenerative medicine methods in the treatment of degenerative injuries of the musculoskeletal system. Knee osteoarthritis (gonarthrosis) is one of the most common reasons for visiting orthopedic surgeons to patients. The purpose of the study was to evaluate the quality of life in patients with different stages of gonarthrosis after application of leukocyte-rich platelet-rich plasma (LR-PRP) and leukocyte-poor platelet-rich plasma (LP-PRP). Materials and methods. The results of the treatment of 48 patients with gonarthrosis grades 1-3 according to Kellgren-Lawrence after intra-articular injection of LR-PRP or LP-PRP were compared. The quality of life questionnaires were used: visual analogue scale, Lysholm Knee Score and Oxford Knee Score before treatment, after the first injection, every 2 weeks before the end of treatment and every 3 months for 1 year. Results. Evaluation of the treatment results obtained at stages 1 and 2 of knee osteoarthritis showed a positive result for both groups of patients during 12 months of follow-up and at stage 3 a significant improvement was achieved for up to 6 months. There was no significant difference between the results of LR-PRP and LP-PRP injections for 9-12 months. After using LP-PRP treatment, the dynamics of quality of life during the year was stepless and more steady, without periods of regression while for LR-PRP injections was a clear significant short-term reduction in the treatment effect for about 6 months, compared to both baseline and values of the previous period at 1 and 2 stages gonarthrosis with further improvement and a stable positive effect for up to 12 months. Conclusions. The application of platelet-rich plasma improved the quality of life for 12 months in patients with stage 1-2 gonarthrosis and for 6 months at stage 3. The obtained positive results substantiate the need for further research to determine the prospects for the application of platelet-rich plasma in the complex treatment of knee osteoarthritis compared to other methods Дод.точки доступу: Goliuk, Ye. Pshenychnyi, T. Ostapenko, T. Yavorovska, V. Magomedov, O. Вільних прим. немає